Business Context and Reporting Period
Company: Stepan Company
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2004
Business Overview: Stepan produces specialty and intermediate chemicals sold to manufacturers for use in detergents, personal care products, plastics, building materials, and food/pharmaceutical applications. The company operates three reportable segments: Surfactants (76% of 2004 sales), Polymers (21%), and Specialty Products (3%).
Key Financial Metrics (2004)
| Metric | 2004 Value | 2003 Value |
|---|---|---|
| Net Sales | $935.8 million | $784.9 million |
| Gross Profit | $111.0 million | $103.7 million |
| Operating Income | $19.2 million | $9.8 million |
| Net Income | $10.3 million | $4.9 million |
| Diluted EPS | $1.05 | $0.45 |
| Operating Cash Flow | $43.9 million | $45.6 million |
| Capital Expenditures | $33.8 million | $32.9 million |
| Total Debt | $112.0 million | $115.7 million |
| Working Capital | $77.9 million | $71.5 million |
| Stockholders' Equity | $168.2 million | $162.1 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 19% ($150.9 million) driven by higher selling prices (passing through raw material costs), favorable foreign currency translation (strengthening Euro, British Pound, and Canadian Dollar), and increased sales volumes across all segments.
- Profitability Surge: Net income rose 110% to $10.3 million. This recovery was aided by the absence of a $1.4 million asset impairment charge recorded in 2003 and a $3.5 million environmental remediation charge in 2003.
- Segment Performance:
- Surfactants: Sales up 14%; operating income flat (+2%) due to high raw material costs in Europe offsetting domestic gains.
- Polymers: Sales up 43%; operating income up 31% driven by volume growth and price increases.
- Specialty Products: Sales up 8%; operating income up 17%.
- Expense Management: Operating expenses declined 2% to $91.8 million, primarily due to lower deferred compensation expense and reduced legal/environmental costs compared to 2003.
Guidance, Outlook, and Risks
Management Outlook: Management is optimistic about 2005, citing favorable business fundamentals in North America. They anticipate continued volume growth in the Polymers segment and improved margins/volume in Europe following a competitor's plant shutdown in the UK. Capital expenditures are projected to increase 10-30% in 2005 to support new facilities in China and Brazil.
Risks and Contingencies:
- Raw Material Volatility: Prices for petroleum and vegetable-based raw materials remain high and volatile. While costs are passed to customers, competitive pressures and contract terms sometimes delay price adjustments, compressing margins.
- Environmental Liabilities: The company is a potentially responsible party at 21 waste disposal sites. A reserve of $18.9 million was recorded at year-end. The estimated range of possible losses is $8.8 million to $40.1 million. Specific sites include Maywood (NJ), Ewan/D'Imperio (NJ), and Wilmington (MA).
- Foreign Currency: Operating results are exposed to exchange rate fluctuations, particularly the Euro and British Pound.
- Deferred Compensation: Compensation expense fluctuates significantly based on the market value of Stepan common stock and mutual funds held in deferred compensation plans.
Investor Verification Checklist
- Raw Material Pass-Through: Verify the company's ability to sustain price increases in 2005 to offset rising input costs, particularly in the European market.
- Environmental Reserve Adequacy: Monitor updates on the Maywood, NJ site remediation and the Ewan/D'Imperio litigation to ensure the $18.9 million reserve remains sufficient.
- Deferred Compensation Impact: Assess the sensitivity of future earnings to fluctuations in the company's stock price, which directly impacts administrative expenses.
- Capital Project Execution: Track the completion and ramp-up of the new China joint venture (polymers) and Brazil facility (surfactants) to ensure projected volume growth materializes.
- Debt Covenants: Confirm continued compliance with loan agreements, noting that amendments were required in 2003 and waivers obtained for European subsidiaries in 2004.